📰 Intersect Ent News
Intersect Ent News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Intersect Ent. Real-time updates on events, politics, business and more.
September 14, 2022
Analysts at StockNews.com assumed coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a research report issued to clients and investors on Wednesday. The brokerage set a “sell” rating on the medical equipment provider’s stock. Intersect ENT Price Performance XENT stock opened at $28.24 on Wednesday. The firm has a market cap of […]
August 29, 2022
/PRNewswire/ -- According to Coherent Market Insights, the global nasal polyps treatment market is estimated to be valued at US$ 2,992.21 Million in 2022 and...
June 10, 2022
StockNews.com started coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a note issued to investors on Friday. The firm set a “sell” rating on the medical equipment provider’s stock. Intersect ENT stock opened at $28.24 on Friday. The stock has a 50-day moving average of $28.03 and a two-hundred day moving average […]
June 5, 2022
Intersect ENT (NASDAQ:XENT – Get Rating) and LMF Acquisition Opportunities (NASDAQ:LMAO – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings. Profitability This table compares Intersect ENT and LMF […]
June 2, 2022
StockNews.com started coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a note issued to investors on Thursday. The brokerage set a “sell” rating on the medical equipment provider’s stock. Shares of NASDAQ:XENT opened at $28.24 on Thursday. The firm’s 50 day moving average is $27.99 and its two-hundred day moving average is […]
May 13, 2022
To get approval for the deal, Medtronic agreed to sell an Intersect subsidiary to soothe the FTC's concerns.
May 1, 2022
Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 2,870,000 shares, a growth of 41.4% from the March 31st total of 2,030,000 shares. Currently, 8.7% of the shares of the company are short […]
April 8, 2022
Calamos Advisors LLC purchased a new position in Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 202,386 shares of the medical equipment provider’s stock, valued at approximately $5,527,000. Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Two […]
April 3, 2022
StockNews.com assumed coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a report issued on Thursday. The brokerage issued a hold rating on the medical equipment provider’s stock. Shares of Intersect ENT stock opened at $27.75 on Thursday. The stock has a 50 day moving average of $27.46 and a 200 day moving […]
March 25, 2022
Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) has been given a consensus recommendation of “Hold” by the six brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. The average 12-month price objective among brokers […]